We will upload information about the latest recipients to have been awarded HRC funding for all of our funding opportunities as this information becomes officially available.

The information provided is for ‘year to date’ funding.

Previous Recipient List

  • 2015 Funding Round - Feasibility Study
    Professor Margreet Vissers
    The University of Otago, Christchurch
    The efficacy and feasibility of modifying tumour metabolism for therapeutic gain
    $100,000
    12 months
  • Feasibility Study Grant (2017)
    Honorary Associate Professor Natalie Walker
    University of Auckland
    Feasibility of a smartphone-based support system for hazardous drinkers
    $187,415
    18 months
  • 2009 Funding Round
    Professor Jim Warren
    The University of Auckland
    Adherence Innovations in Medication use for Health Improvement (AIM-HI)
    $147,617
    12
  • 2013 Funding Round
    Dr Robert Weinkove
    Malaghan Institute of Medical Research
    A randomised placebo-controlled trial of paracetamol in febrile neutropenia
    $148,512
    12 months
  • 2012 Funding Round
    Professor John Windsor
    The University of Auckland
    Redefining the Basics: Goal Directed Fluid Therapy in Acute Pancreatitis
    $148,852
    12 months
  • 2014 Funding Round – Feasibility Study
    Dr Conroy Wong
    Centre for Clinical Research Effective Practice
    Antimicrobial and anti-inflammatory effects of nicotinamide in bronchiectasis
    $150,000
    12 months
  • 2015 Funding Round - Feasibility Study
    Dr Conroy Wong
    Centre for Clinical Research and Effective Practice
    Anti-inflammatory effects of oral and transdermal clonidine in bronchiectasis
    $149,696
    12 months
  • 2013 Funding Round
    Dr Paul Young
    Medical Research Institute of New Zealand
    Feasibility study of normoxic versus hyperoxic therapy after cardiac arrest
    $148,875
    12 months
  • 2014 Funding Round – Feasibility Study
    Associate Professor Robert Young
    Centre for Clinical Research Effective Practice
    Simvastatin treatment for patients with chronic obstructive pulmonary disease (COPD) and elevated C-reactive protein
    $149,660
    12 months
  • 2016 funding round - Feasibility Study
    Dr Paul Young
    Medical Research Institute of New Zealand
    Paracetamol therapy in critical illness
    $149,798
    12 months
  • 2014 Funding Round – Feasibility Study
    Dr Caryn Zinn
    AUT University
    Carbohydrate-restricted diets in the treatment of obesity in children
    $150,000
    12 months